Please login to the form below

esomeprazole

This page shows the latest esomeprazole news and features for those working in and with pharma, biotech and healthcare.

AZ expects return to growth this year after 2017 decline

to $2.6bn, although the cumulative effect of patent expiries - which also affect antipsychotic Seroquel XR (quetiapine) and gastrointestinal drug Nexium (esomeprazole) - are starting to dissipate.

Latest news

AZ sells Zurampic rights to Gruenenthal for $230m

light of the loss of patent protection for blockbuster brands such as cholesterol drug Crestor (rosuvastatin) and Nexium (esomeprazole) for gastrointestinal diseases.
AZ adds gout drug Zurampic to asset sale

The deal gives AZ another cash injection as it weathers the loss of blockbuster brands such as cholesterol drug Crestor (rosuvastatin) and Nexium (esomeprazole) for gastrointestinal diseases and brings new pipeline
AZ offloads more products in slimming drive

years, including cholesterol drug Crestor (rosuvastatin) and Nexium (esomeprazole) for gastrointestinal indications.
AZ boosts cardio-renal portfolio with $2.7bn ZS Pharma buy

The UK firm has just announced its third-quarter results, which saw sales slip 10% to $5.9bn mainly as a result of generic competition to gastrointestinal drug Nexium (esomeprazole) which
Bio investors react as Clinton tweet pledges pricing crackdown

in the price of Vimovo (naproxen/esomeprazole magnesium), a pain drug acquired from AstraZeneca in 2013.

More from news
Approximately 2 fully matching, plus 42 partially matching documents found.

Latest Intelligence

Pharma deals during March 2014

Horizon's arthritis and anti-inflammatory products are novel formulations/combinations of established drugs: Duexis (ibuprofen and famotidine), Vimovo (naproxen and esomeprazole) and Rayos/Lodotra (delayed release prednisone). Vidara brings
Ireland and the impact of reference pricing

After cholesterol-lowering drugs, which represent the highest cost in the reimbursable category, came esomeprazole, for stomach conditions, and other drugs considered high priority for the management of chronic conditions.
Pharma deals during October 2012

As a further dimension to their relationship, the companies also announced a co-promotion agreement in the US for AZ's Nexium (esomeprazole magnesium) for gastroesophageal reflux disease (GERD). Many patients

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

Evan Lippman joins Aileron Therapeutics

Highlights of his career include a spell as executive director at AstraZeneca where he led on huge brands such as Crestor (rosuvastatin calcium) and Nexium (esomeprazole) and heading US business development

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

PR Director – Health & Wellbeing – Mat Cover (4 days a week)...: Salary TBC

Senior Medical Writer: Salary TBC

Account/ Project Director – Medical Affairs – Surrey: Salary TBC

Editorial Assistant Medical Education Agency: £25, 000 - £26, 000

Senior Planner – Healthcare Advertising – New Role: Salary TBC

Account Director, Medical Education: Salary TBC

AD – Corporate Comms/ Public Affairs/ B2B – Healthcare Focus: Salary TBC

Project/ Events Manager – Medical Education and Events Agency: Salary TBC

Account Director, Healthcare Marketing Agency: Salary TBC

Senior Medical Writer: Great salary and benefits

Account Manager, MedicalCommunications/ Healthcare PR: benefits

Account Manager, Medical Communications and Marketing: £30, 000 – £40, 000 benefits and bonus

Senior Medical Writer: Up to £50, 000 with Benefits

Digital Account Director: Salary TBC

Project Manager/ Account Manager: Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

AMICULUM Limited

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

The importance of co-creation with patients: Overcoming the barriers...
Three billboards on the road to multichannel: Chris Ross examines the trends driving multichannel communication in 2019...
How Medisafe is using AI to improve patient adherence: Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....